Moderna, Novavax Stocks Fall After Top FDA Vaccine Official Forced Out
Oops, something went wrong
Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Shares in Moderna and Novavax fell Monday, following a Wall Street Journal report that the Food and Drug Administration’s top vaccine official has been pushed out. Shares in some larger drugmakers, such as GSK, also retreated.